Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$7.28 - $14.32 $728 - $1,432
100 Added 25.0%
500 $7,000
Q4 2021

Feb 14, 2022

BUY
$17.83 - $33.15 $1,069 - $1,989
60 Added 17.65%
400 $8,000
Q2 2021

Aug 09, 2021

BUY
$32.66 - $39.87 $489 - $598
15 Added 4.62%
340 $12,000
Q4 2020

Feb 16, 2021

BUY
$33.22 - $50.26 $10,796 - $16,334
325 New
325 $11,000

Others Institutions Holding PHAT

About Phathom Pharmaceuticals, Inc.


  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $292M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Tradition Wealth Management, LLC Portfolio

Follow Tradition Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradition Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradition Wealth Management, LLC with notifications on news.